Literature review of human papillomavirus vaccine acceptability among women over 26 years

Lora L. Black, Gregory Zimet, Mary B. Short, Lynne Sturm, Susan L. Rosenthal

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Vaccines for the human papillomavirus (HPV) are currently licensed for females, ages 9 through 26 years old in the U.S., and for adult women up to 45 years in some countries such as Australia. As licensure for adult women, over 26 years, is sought in other countries, it will be important to determine the acceptability to them. We reviewed the available articles on adult opinions and acceptability of vaccinating women against HPV. Predictors of acceptability included barriers, knowledge, risk, age, and marital status. Overall, acceptability rates were high, if adequate information was given and the cost was affordable.

Original languageEnglish
Pages (from-to)1668-1673
Number of pages6
JournalVaccine
Volume27
Issue number11
DOIs
StatePublished - Mar 10 2009

Fingerprint

Papillomavirus Vaccines
Papillomaviridae
vaccines
marital status
Marital Status
Licensure
Costs and Cost Analysis

Keywords

  • Acceptability
  • Adult women
  • Human papillomavirus vaccine
  • Sexually transmitted diseases

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Literature review of human papillomavirus vaccine acceptability among women over 26 years. / Black, Lora L.; Zimet, Gregory; Short, Mary B.; Sturm, Lynne; Rosenthal, Susan L.

In: Vaccine, Vol. 27, No. 11, 10.03.2009, p. 1668-1673.

Research output: Contribution to journalArticle

Black, Lora L. ; Zimet, Gregory ; Short, Mary B. ; Sturm, Lynne ; Rosenthal, Susan L. / Literature review of human papillomavirus vaccine acceptability among women over 26 years. In: Vaccine. 2009 ; Vol. 27, No. 11. pp. 1668-1673.
@article{d2e08f5d1e4c46a28a117a418c8a0db5,
title = "Literature review of human papillomavirus vaccine acceptability among women over 26 years",
abstract = "Vaccines for the human papillomavirus (HPV) are currently licensed for females, ages 9 through 26 years old in the U.S., and for adult women up to 45 years in some countries such as Australia. As licensure for adult women, over 26 years, is sought in other countries, it will be important to determine the acceptability to them. We reviewed the available articles on adult opinions and acceptability of vaccinating women against HPV. Predictors of acceptability included barriers, knowledge, risk, age, and marital status. Overall, acceptability rates were high, if adequate information was given and the cost was affordable.",
keywords = "Acceptability, Adult women, Human papillomavirus vaccine, Sexually transmitted diseases",
author = "Black, {Lora L.} and Gregory Zimet and Short, {Mary B.} and Lynne Sturm and Rosenthal, {Susan L.}",
year = "2009",
month = "3",
day = "10",
doi = "10.1016/j.vaccine.2009.01.035",
language = "English",
volume = "27",
pages = "1668--1673",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - Literature review of human papillomavirus vaccine acceptability among women over 26 years

AU - Black, Lora L.

AU - Zimet, Gregory

AU - Short, Mary B.

AU - Sturm, Lynne

AU - Rosenthal, Susan L.

PY - 2009/3/10

Y1 - 2009/3/10

N2 - Vaccines for the human papillomavirus (HPV) are currently licensed for females, ages 9 through 26 years old in the U.S., and for adult women up to 45 years in some countries such as Australia. As licensure for adult women, over 26 years, is sought in other countries, it will be important to determine the acceptability to them. We reviewed the available articles on adult opinions and acceptability of vaccinating women against HPV. Predictors of acceptability included barriers, knowledge, risk, age, and marital status. Overall, acceptability rates were high, if adequate information was given and the cost was affordable.

AB - Vaccines for the human papillomavirus (HPV) are currently licensed for females, ages 9 through 26 years old in the U.S., and for adult women up to 45 years in some countries such as Australia. As licensure for adult women, over 26 years, is sought in other countries, it will be important to determine the acceptability to them. We reviewed the available articles on adult opinions and acceptability of vaccinating women against HPV. Predictors of acceptability included barriers, knowledge, risk, age, and marital status. Overall, acceptability rates were high, if adequate information was given and the cost was affordable.

KW - Acceptability

KW - Adult women

KW - Human papillomavirus vaccine

KW - Sexually transmitted diseases

UR - http://www.scopus.com/inward/record.url?scp=60849134553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60849134553&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.01.035

DO - 10.1016/j.vaccine.2009.01.035

M3 - Article

VL - 27

SP - 1668

EP - 1673

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -